Terms: = Colorectal cancer AND POT1, DKFZP586D211, 25913, ENSG00000128513, hPot1, DKFZp586D211
18 results:
1. A
Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
[TBL] [Abstract] [Full Text] [Related]
2. Telomere Length as a New Risk Marker of Early-Onset colorectal cancer.
Martel-Martel A; Corchete LA; Martí M; Vidal-Tocino R; Hurtado E; Álvaro E; Jiménez F; Jiménez-Toscano M; Balaguer F; Sanz G; López I; Hernández-Villafranca S; Ballestero A; Vivas A; Melone S; Pastor C; Brandáriz L; Gómez-Marcos MA; Cruz-Hernández JJ; Perea J; González-Sarmiento R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834938
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Characterization of Peritoneal Mesotheliomas.
Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
[TBL] [Abstract] [Full Text] [Related]
4. Telomere Maintenance Variants and Survival after colorectal cancer: Smoking- and Sex-Specific Associations.
Yin H; Hardikar S; Lindstroem S; Hsu L; Anderson KE; Banbury BL; Berndt SI; Chan AT; Giovanucci EL; Harrison TA; Joshi AD; Nan H; Potter JD; Sakoda LC; Slattery ML; Schoen RE; White E; Peters U; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1817-1824. PubMed ID: 32586834
[TBL] [Abstract] [Full Text] [Related]
5. Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review.
Belhadj S; Terradas M; Munoz-Torres PM; Aiza G; Navarro M; Capellá G; Valle L
Hum Mutat; 2020 Sep; 41(9):1563-1576. PubMed ID: 32449991
[TBL] [Abstract] [Full Text] [Related]
6.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract] [Full Text] [Related]
7. The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients.
Aljarbou F; Almousa N; Bazzi M; Aldaihan S; Alanazi M; Alharbi O; Almadi M; Aljebreen AM; Azzam NA; Arafa M; Aldbass A; Shaik J; Alasirri S; Warsy A; Alamri A; Parine NR; Alamro G
PLoS One; 2018; 13(6):e0197154. PubMed ID: 29870526
[TBL] [Abstract] [Full Text] [Related]
8. The wide spectrum of pot1 gene variants correlates with multiple cancer types.
Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
[TBL] [Abstract] [Full Text] [Related]
9. Telomere structure and maintenance gene variants and risk of five cancer types.
Karami S; Han Y; Pande M; Cheng I; Rudd J; Pierce BL; Nutter EL; Schumacher FR; Kote-Jarai Z; Lindstrom S; Witte JS; Fang S; Han J; Kraft P; Hunter DJ; Song F; Hung RJ; McKay J; Gruber SB; Chanock SJ; Risch A; Shen H; Haiman CA; Boardman L; Ulrich CM; Casey G; Peters U; Amin Al Olama A; Berchuck A; Berndt SI; Bezieau S; Brennan P; Brenner H; Brinton L; Caporaso N; Chan AT; Chang-Claude J; Christiani DC; Cunningham JM; Easton D; Eeles RA; Eisen T; Gala M; Gallinger SJ; Gayther SA; Goode EL; Grönberg H; Henderson BE; Houlston R; Joshi AD; Küry S; Landi MT; Le Marchand L; Muir K; Newcomb PA; Permuth-Wey J; Pharoah P; Phelan C; Potter JD; Ramus SJ; Risch H; Schildkraut J; Slattery ML; Song H; Wentzensen N; White E; Wiklund F; Zanke BW; Sellers TA; Zheng W; Chatterjee N; Amos CI; Doherty JA;
Int J Cancer; 2016 Dec; 139(12):2655-2670. PubMed ID: 27459707
[TBL] [Abstract] [Full Text] [Related]
10. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
Chubb D; Broderick P; Dobbins SE; Frampton M; Kinnersley B; Penegar S; Price A; Ma YP; Sherborne AL; Palles C; Timofeeva MN; Bishop DT; Dunlop MG; Tomlinson I; Houlston RS
Nat Commun; 2016 Jun; 7():11883. PubMed ID: 27329137
[TBL] [Abstract] [Full Text] [Related]
11. Recent developments in brain tumor predisposing syndromes.
Johansson G; Andersson U; Melin B
Acta Oncol; 2016; 55(4):401-11. PubMed ID: 26634384
[TBL] [Abstract] [Full Text] [Related]
12. POLE mutations in families predisposed to cutaneous melanoma.
Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK
Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183
[TBL] [Abstract] [Full Text] [Related]
13. Telomere 1 (pot1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Izgi A; Gunal A; Yalcin S; Gunduz U
Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
[TBL] [Abstract] [Full Text] [Related]
14. T-oligo as an anticancer agent in colorectal cancer.
Wojdyla L; Stone AL; Sethakorn N; Uppada SB; Devito JT; Bissonnette M; Puri N
Biochem Biophys Res Commun; 2014 Apr; 446(2):596-601. PubMed ID: 24632202
[TBL] [Abstract] [Full Text] [Related]
15. Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.
Kojima K; Hiyama E; Otani K; Ohtaki M; Fukuba I; Fukuda E; Sueda T; Hiyama K
Cancer Sci; 2011 Feb; 102(2):330-5. PubMed ID: 21108695
[TBL] [Abstract] [Full Text] [Related]
16. Altered mRNA expression of telomere binding proteins (TPP1, pot1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract] [Full Text] [Related]
17. Variation of the 3' telomeric overhang lengths in human cells.
Lee ME; Rha SY; Jeung HC; Kim TS; Chung HC; Oh BK
Cancer Lett; 2008 Jun; 264(1):107-18. PubMed ID: 18316158
[TBL] [Abstract] [Full Text] [Related]
18. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Incles CM; Schultes CM; Kelland LR; Neidle S
Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
[TBL] [Abstract] [Full Text] [Related]
